Common side effects of Opicapone and how to deal with them

As a long-acting COMT inhibitor, Opicapone has significant clinical value in the management of "on-off" symptoms of Parkinson's disease, but like all drugs, it may also bring about a series of side effects. Recognizing these common adverse reactions and taking corresponding treatment measures is the key to ensuring the continuity of treatment and quality of life of patients.

Among the known side effects, the most common are motor complications related to the potentiation of levodopa, especially in the first few weeks after initiating opicapone treatment. Some patients may experience hypertonia, increased tremor, or involuntary movements (such as dyskinesia), which are often caused by high levodopa concentrations. The main clinical response is to moderately reduce the total daily dose of levodopa or adjust the interval between doses, which can usually effectively relieve symptoms.

In terms of non-exercise side effects, Opicapone may cause mild discomfort such as constipation, dry mouth, headache, drowsiness, and insomnia. Most of these side effects are short-term or reversible and usually gradually reduce as the body adapts to the drug. If constipation persists, it can be relieved by adjusting the diet, increasing dietary fiber intake, and moderate use of laxative drugs. If obvious insomnia or daytime sleepiness occurs, the medication time can be adjusted appropriately and avoid taking it at night.

Some patients may also experience gastrointestinal reactions such as nausea and bloating when taking Opicapone for the first time. This type of reaction is common in the dose initiation phase. It is recommended to take it with a small amount of food (be careful to avoid high-fat meals) or adopt a gradual dose escalation strategy to help tolerance. It is worth noting that the side effects of opicapone may be more pronounced in elderly patients or those with multiple chronic diseases, so individualized risks need to be assessed in conjunction with the overall health status.

Reference materials:https://www.ongentys.com/